Vertex Pharmaceuticals Inc (VRTX)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 22,533,200 | 22,730,200 | 18,150,900 | 13,432,500 | 11,751,800 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $22,533,200K
= 0.00
The debt-to-assets ratio for Vertex Pharmaceuticals Inc has consistently remained at 0.00 from December 31, 2020, through December 31, 2024. This indicates that the company has not had any financial leverage in its capital structure during this period. A ratio of 0.00 means that the company has no debt in relation to its total assets. Vertex Pharmaceuticals Inc appears to have a strong financial position with no significant debt obligations, which can be viewed positively by investors and creditors as it signifies a lower level of financial risk.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
Vertex Pharmaceuticals Inc
VRTX
0.00
Abbott Laboratories
ABT
0.19
AbbVie Inc
ABBV
0.00
Alkermes Plc
ALKS
0.00
Amphastar P
AMPH
0.39
ANI Pharmaceuticals Inc
ANIP
0.31
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.51
Catalent Inc
CTLT
0.00
Catalyst Pharmaceuticals Inc
CPRX
0.00